Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
Search by expertise, name or affiliation
Treatment of hepatitis C virus infection in the allograft
James Neuberger
Cancer and Genomic Sciences
Research output
:
Contribution to journal
›
Review article
20
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment of hepatitis C virus infection in the allograft'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Allograft
100%
Hepatitis C Virus
100%
Hepatitis C Virus Infection
100%
Pretransplant
66%
Ribavirin
66%
Quality of Life
33%
Interferon-α (IFN-α)
33%
Recurrence Rate
33%
Prospective Randomized Trial
33%
Immunosuppression
33%
Viral Replication
33%
Acute Rejection
33%
Graft Damage
33%
Treatment Duration
33%
Graft Survival
33%
Split Liver Transplantation
33%
Virus Hepatitis
33%
Ischemic Time
33%
Hepatitis C Virus Recurrence
33%
Best Medical Treatment
33%
Older Donors
33%
Treatment Needs
33%
Preemptive Treatment
33%
Pegylated Interferon
33%
Treatment Side Effects
33%
Immunology and Microbiology
Allograft
100%
Hepatitis C Virus
100%
Hepatitis C
100%
Ribavirin
50%
Viral Replication
25%
Immunosuppression
25%
interferon
25%
Acute Graft Rejection
25%
Hepatitis Virus
25%
Pegylated Interferon
25%